The different roles of ER subtypes in cancer biology and therapy (Q37903655)

25 August 2017

1 reference

title

The different roles of ER subtypes in cancer biology and therapy (English)

1 reference

25 August 2017

Christoforos Thomas

1

1 reference

25 August 2017

Jan-Åke Gustafsson

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

22 July 2011

1 reference

25 August 2017

Nature Reviews Cancer

1 reference

25 August 2017

11

1 reference

25 August 2017

8

1 reference

25 August 2017

597-608

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3093

25 August 2017

0 references

cites work

Estrogen receptors: how do they signal and what are their targets

1 reference

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization

31 March 2020

1 reference

Cloning of the human estrogen receptor cDNA

31 March 2020

1 reference

Cloning of a novel receptor expressed in rat prostate and ovary

31 March 2020

1 reference

Estrogen receptor mutations in human disease

31 March 2020

1 reference

Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes

31 March 2020

1 reference

Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer

31 March 2020

1 reference

Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones

31 March 2020

1 reference

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis

31 March 2020

1 reference

Treating prostate cancer: a rationale for targeting local oestrogens

31 March 2020

1 reference

ERbeta in breast cancer--onlooker, passive player, or active protector?

31 March 2020

1 reference

ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates.

31 March 2020

1 reference

Biological determinants of endocrine resistance in breast cancer

31 March 2020

1 reference

Clinical importance of estrogen receptor beta isoforms in breast cancer.

31 March 2020

1 reference

Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome

31 March 2020

1 reference

Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.

31 March 2020

1 reference

Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth.

31 March 2020

1 reference

Ligand-independent and agonist-mediated degradation of estrogen receptor-alpha in breast carcinoma cells: evidence for distinct degradative pathways

31 March 2020

1 reference

Regulation of estrogen receptor beta activity and implications in health and disease

31 March 2020

1 reference

Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

31 March 2020

1 reference

Localization of the human oestrogen receptor gene to chromosome 6q24----q27 by in situ hybridization

31 March 2020

1 reference

Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways

31 March 2020

1 reference

Genome-wide analysis of estrogen receptor binding sites

31 March 2020

1 reference

Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences

31 March 2020

1 reference

Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers

31 March 2020

1 reference

Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae

31 March 2020

1 reference

Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities

31 March 2020

1 reference

Plasma membrane estrogen receptors exist and functions as dimers

31 March 2020

1 reference

Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway

31 March 2020

1 reference

Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation

31 March 2020

1 reference

ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus

31 March 2020

1 reference

Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors

31 March 2020

1 reference

Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.

31 March 2020

1 reference

Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression

31 March 2020

1 reference

Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis

31 March 2020

1 reference

Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma

31 March 2020

1 reference

Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer

31 March 2020

1 reference

Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway

31 March 2020

1 reference

The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells

31 March 2020

1 reference

The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.

31 March 2020

1 reference

MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells

31 March 2020

1 reference

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

31 March 2020

1 reference

Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer

31 March 2020

1 reference

miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA

31 March 2020

1 reference

Hsp90: chaperoning signal transduction

31 March 2020

1 reference

Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents

31 March 2020

1 reference

E6AP and calmodulin reciprocally regulate estrogen receptor stability.

31 March 2020

1 reference

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.

31 March 2020

1 reference

Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.

31 March 2020

1 reference

Mammary gland development and tumorigenesis in estrogen receptor knockout mice

31 March 2020

1 reference

Insights from the study of animals lacking functional estrogen receptor

31 March 2020

1 reference

Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice

31 March 2020

1 reference

Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis

31 March 2020

1 reference

Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium.

31 March 2020

1 reference

Direct response of the murine prostate gland and seminal vesicles to estradiol.

31 March 2020

1 reference

Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life

31 March 2020

1 reference

Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements

31 March 2020

1 reference

Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.

31 March 2020

1 reference

Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor

31 March 2020

1 reference

Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling

31 March 2020

1 reference

Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium

31 March 2020

1 reference

Estrogen receptor beta in prostate cancer

31 March 2020

1 reference

Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate

31 March 2020

1 reference

A role for estrogen receptor beta in the regulation of growth of the ventral prostate

31 March 2020

1 reference

Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant

31 March 2020

1 reference

Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.

31 March 2020

1 reference

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

31 March 2020

1 reference

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

31 March 2020

1 reference

Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice

31 March 2020

1 reference

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells

31 March 2020

1 reference

Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts

31 March 2020

1 reference

Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling

31 March 2020

1 reference

Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells

31 March 2020

1 reference

ERbeta exerts multiple stimulative effects on human breast carcinoma cells

31 March 2020

1 reference

Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells

31 March 2020

1 reference

The nuclear receptor superfamily: the second decade

31 March 2020

1 reference

Estrogen receptor mutations and changes in downstream gene expression and signaling

31 March 2020

1 reference

ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways

31 March 2020

1 reference

Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues

31 March 2020

1 reference

Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach

31 March 2020

1 reference

Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer

31 March 2020

1 reference

Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance

31 March 2020

1 reference

Cloning and characterization of human estrogen receptor beta isoforms

31 March 2020

1 reference

Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7

31 March 2020

1 reference

Putative functional characteristics of human estrogen receptor-beta isoforms

31 March 2020

1 reference

The potential role of ER beta isoforms in the clinical management of breast cancer

31 March 2020

1 reference

Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients

31 March 2020

1 reference

Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers.

31 March 2020

1 reference

Estrogen receptor beta acts as a dominant regulator of estrogen signaling

31 March 2020

1 reference

Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.

31 March 2020

1 reference

ERalpha signaling through slug regulates E-cadherin and EMT.

31 March 2020

1 reference

ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading

31 March 2020

1 reference

Different roles of estrogen receptors alpha and beta in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line

31 March 2020

1 reference

Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells

31 March 2020

1 reference

Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.

31 March 2020

1 reference

Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model

31 March 2020

1 reference

Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling

31 March 2020

1 reference

Estrogen receptor null mice: what have we learned and where will they lead us?

31 March 2020

1 reference

Estrogen receptors and human disease

31 March 2020

1 reference

Aromatase expression predicts survival in women with early-stage non small cell lung cancer

31 March 2020

1 reference

31 March 2020

Hormonal carcinogenesis

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

31 March 2020

1 reference

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

31 March 2020

1 reference

Aromatase inhibitors for breast cancer: lessons from the laboratory

31 March 2020

1 reference

Selective aromatase inhibition for patients with androgen-independent prostate carcinoma

31 March 2020

1 reference

Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors.

31 March 2020

1 reference

Increased estrogen receptor betacx expression during mammary carcinogenesis

31 March 2020

1 reference

Progesterone receptor expression in human prostate cancer: correlation with tumor progression

31 March 2020

1 reference

Estrogen receptor gene amplification occurs rarely in ovarian cancer

31 March 2020

1 reference

Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression

31 March 2020

1 reference

Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.

31 March 2020

1 reference

ESR1 amplification in endometrial carcinomas: hope or hyperbole?

31 March 2020

1 reference

Wild-type estrogen receptor (ERbeta1) and the splice variant (ERbetacx/beta2) are both expressed within the human endometrium throughout the normal menstrual cycle

31 March 2020

1 reference

Evaluation of mRNA expression of estrogen receptor beta and its isoforms in human normal and neoplastic endometrium

31 March 2020

1 reference

Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma

31 March 2020

1 reference

The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity

31 March 2020

1 reference

Coregulator function: a key to understanding tissue specificity of selective receptor modulators

31 March 2020

1 reference

Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta

31 March 2020

1 reference

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway

31 March 2020

1 reference

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas

31 March 2020

1 reference

Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer

31 March 2020

1 reference

Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer

31 March 2020

1 reference

Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo

31 March 2020

1 reference

Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen

31 March 2020

1 reference

Phosphorylation of ERα at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERα phosphorylation in breast cancer progression

31 March 2020

1 reference

Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer

31 March 2020

1 reference

Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer

31 March 2020

1 reference

Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer

31 March 2020

1 reference

Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion

31 March 2020

1 reference

Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.

31 March 2020

1 reference

Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer

31 March 2020

1 reference

BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.

31 March 2020

1 reference

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen

31 March 2020

1 reference

Endocrine-responsive breast cancer and strategies for combating resistance

31 March 2020

1 reference

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

31 March 2020

1 reference

Mechanisms of tamoxifen resistance

31 March 2020

1 reference

Bortezomib enhances the efficacy of fulvestrant by amplifying the aggregation of the estrogen receptor, which leads to a proapoptotic unfolded protein response

31 March 2020

1 reference

Activation and clinical significance of the unfolded protein response in breast cancer

31 March 2020

1 reference

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy

31 March 2020

1 reference

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study

31 March 2020

1 reference

Exon deletions and variants of human estrogen receptor mRNA in endometrial hyperplasia and adenocarcinoma

31 March 2020

1 reference

Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.

31 March 2020

1 reference

Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung

31 March 2020

1 reference

Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lung.

31 March 2020

1 reference

Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation

31 March 2020

1 reference

Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex.

31 March 2020

1 reference

Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival

31 March 2020

1 reference

Gonadotropin and steroid receptors as prognostic factors in advanced ovarian cancer: a retrospective study

31 March 2020

1 reference

Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.

31 March 2020

1 reference

Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies

31 March 2020

1 reference

Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary

31 March 2020

1 reference

Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas

31 March 2020

1 reference

Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.

31 March 2020

1 reference

Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice

31 March 2020

1 reference

ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components.

31 March 2020

1 reference

Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2.

31 March 2020

1 reference

Involvement of estrogen receptor beta in ovarian carcinogenesis

31 March 2020

1 reference

Gonadotropin-positive pituitary tumors accompanied by ovarian tumors in aging female ERbeta-/- mice

31 March 2020

1 reference

A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.

31 March 2020

1 reference

12 December 2020

Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern

1 reference

12 December 2020

Absence of estrogen receptor-beta expression in metastatic ovarian cancer

1 reference

12 December 2020

Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression

1 reference

12 December 2020

Metastatic prostate cancer in a transgenic mouse

1 reference

12 December 2020

Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation

1 reference

12 December 2020

Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging.

1 reference

12 December 2020

Crossroads of estrogen receptor and NF-kappaB signaling

1 reference

12 December 2020

Chemoprevention strategies for prostate cancer

1 reference

12 December 2020

Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice.

1 reference

12 December 2020

Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?

1 reference

12 December 2020

Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model

1 reference

12 December 2020

AIB1 enhances estrogen-dependent induction of cyclin D1 expression

1 reference

12 December 2020

Differential expression of estrogen receptor beta isoforms in human breast cancer tissue

1 reference

12 December 2020

Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

1 reference

12 December 2020

Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes

1 reference

12 December 2020

Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line

1 reference

12 December 2020

Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu.

1 reference

12 December 2020

Mechanism of estrogen activation of c-myc oncogene expression

1 reference

12 December 2020

Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu

1 reference

12 December 2020

Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.

1 reference

12 December 2020

Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity

1 reference

12 December 2020

Remarks on Oöphorectomy in the Treatment of Cancer of the Breast.

1 reference

12 December 2020

Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression

1 reference

12 December 2020

The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers

1 reference

12 December 2020

Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.

1 reference

12 December 2020

Selective loss of estrogen receptor beta in malignant human colon

1 reference

12 December 2020

Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation

1 reference

12 December 2020

Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis.

1 reference

12 December 2020

Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.

1 reference

12 December 2020

Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3093

1 reference

Dimensions Publication ID

25 August 2017

0 references

1 reference